Effect of helicobacter pylori eradication on hepatic encephalopathy

Hepatitis Monthly

Volumn 8, Issue 2, 2008, Pages 121-124

  Shavakhi, Ahmad ^a   Shariatifar, Behzad ^b   Chuloo, Shadan Akhtar ^b   Minakari, Mohammad ^a   Somi, Mohammad Hossein ^c  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cirrhosis; Helicobacter pylori; Hepatic encephalopathy

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; BISMUTH; LACTULOSE; METRONIDAZOLE; OMEPRAZOLE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; ENDOSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLAPPING TREMOR; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; MALE; SERODIAGNOSIS; STATISTICAL SIGNIFICANCE;

EID: 46649097035     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Rekha C, Phanidhar MS, Sagar AV, Revathi A, Asra WA. Role of Helicobacter pylori and hyperammonemia in subclinical hepatic encephalopathy in cirrhosis of liver. Indian J Clin Biochem 2007; 22: 136-9.
2. DuBois S, Eng S, Bhattacharya R, Rulyak S, Hubbard T, Putnam D, et al. Breath ammonia testing for diagnosis of hepatic encephalopathy. Dig Dis Sci 2005; 50: 1780-4.
3. Demirturk L, Yazgan Y, Zci O, Ozel M, Togrol E, Gultepe M, et al. The effect of Helicobacter pylori eradication on gastric juice and blood ammonia concentrations and on visual evoked potentials in cirrhotics. Helicobacter 2001; 6: 325-30.
4. Summerskill WH, Wolpert E. Ammonia metabolism in the gut. Am J Clin Nutr 1970; 23: 633-9.
5. Ponzetto A, Fagoonee S, Pellicano R. Helicobacter pylori and liver: an actor with three roles? Dig Liver Dis 2001; 33: 399-401.
6. Chakrabarti P, Zullo A, Hassan C, Pandit A, Chowdhury A, Santra A, et al. Helicobacter pylori, gastric juice, and arterial ammonia levels in patients with cirrhosis. J Clin Gastroenterol 2002; 34: 578-81.
7. Triebling AT, Korsten MA, Dlugosz JW, Paronetto F, Lieber CS. Severity of Helicobacter-induced gastric injury correlates with gastric juice ammonia. Dig Dis Sci 1991; 36: 1089-96.
8. Dasani BM, Sigal SH, Lieber CS. Analysis of risk factors for chronic hepatic encephalopathy: the role of Helicobacter pylori infection. Am J Gastroenterol 1998; 93: 726-31.
9. Ito S, Kohli Y, Kato T, Abe Y, Ueda T. Significance of ammonia produced by Helicobacter pylori. Eur J Gastroenterol Hepatol 1994; 6: 167-74.
10. Calvet X, Nogueras C, Roque M, Sanfeliu I. Helicobacter pylori is not a risk factor for hepatic encephalopathy. Dig Liver Dis 2001; 33: 414-9.
11. Scotiniotis IA, Lucey MR, Metz DC. Helicobacter pylori infection is not associated with subclinical hepatic encephalopathy in stable cirrhotic patients. Dig Dis Sci 2001; 46: 2744-51.
12. Conn HO, Leevy CM, Vlahcevic ZR, Rodgers JB, Maddrey WC, Seeff L, et al. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial. Gastroenterology 1977; 72: 573-83.
13. Riordan SM, Williams R. Treatment of hepatic encephalopathy. N Engl J Med 1997; 337: 473-9.
14. Capocaccia L, Merli M, Piat C, Servi R, Zullo A, Riggio O. Zinc and other trace elements in liver cirrhosis. Ital J Gastroenterol 1991; 23: 386-91.
15. Gilbert JV, Ramakrishna J, Sunderman FW, Jr., Wright A, Plaut AG. Protein Hpn: cloning and characterization of a histidine-rich metal-binding polypeptide in Helicobacter pylori and Helicobacter mustelae. Infect Immun 1995; 63: 2682-8.
16. Riggio O, Merli M, Capocaccia L, Caschera M, Zullo A, Pinto G, et al. Zinc supplementation reduces blood ammonia and increases liver ornithine transcarbamylase activity in experimental cirrhosis. Hepatology 1992; 16: 785-9.
17. Miyaji H, Ito S, Azuma T, Ito Y, Yamazaki Y, Ohtaki Y, et al. Effects of Helicobacter pylori eradication therapy on hyperammonaemia in patients with liver cirrhosis. Gut 1997; 40: 726-30.
18. Vasconez C, Elizalde JI, Llach J, Gines A, de la Rosa C, Fernandez RM, et al. Helicobacter pylori, hyperammonemia and subclinical portosystemic encephalopathy: effects of eradication. J Hepatol 1999; 30: 260-4.
19. Miquel J, Barcena R, Boixeda D, Fernandez J, SanRoman AL, Martin-de-Argila C, et al. Role of Helicobacter pylori infection and its eradication in patients with subclinical hepatic encephalopathy. Eur J Gastroenterol Hepatol 2001; 13: 1067-72.
20. Zullo A, Rinaldi V, Hassan C, Folino S, Winn S, Pinto G, et al. Helicobacter pylori and plasma ammonia levels in cirrhotics: role of urease inhibition by acetohydroxamic acid. Ital J Gastroenterol Hepatol 1998; 30: 405-9.
21. Yanai A, Maeda S, Hikiba Y, Shibata W, Ohmae T, Hirata Y, et al. Clinical relevance of Helicobacter pylori sabA genotype in Japanese clinical isolates. J Gastroenterol Hepatol 2007; 22: 2228-32.